Jim Cramer Recently Discussed These 17 Stocks And Chinese Hackers

8. Novo Nordisk A/S (NYSE:NVO)

Number of Hedge Fund Holders In Q3 2024: 61

Novo Nordisk A/S (NYSE:NVO) is a Danish pharmaceutical company that is one of the leading players in the global weight loss drug market. Cramer’s recent comments about the firm wondered whether the incoming Trump administration could target it to negotiate with Denmark to cede Greenland to the US. Novo Nordisk A/S (NYSE:NVO)’s shares are down by 26.8% over the past year after having dealt a hefty 17.8% blow in December after its weight loss drug trial missed investor expectations. Cramer’s latest comments for Novo Nordisk A/S (NYSE:NVO) surrounded its weight loss drugs being picked for Medicare price negotiations:

“[On weight loss drugs being part of Medicare] I think that there are a lot of people who felt that this had to happen. Uh, David Ricks, would be one of them, the CEO of Lilly. I think that you don’t have comorbidities with these and it’s going to be difficult. Otherwise they would, you know you talk about eight billion dollars, maybe for Novo, and Lilly’s drug is superior in terms of weight reduction at the same dose. No one thought that they would be able to just run amok. And I think that while the stocks are down, it’s going to be the greatest drug of all time. And everybody knows that. The persistence level of people who take it is much higher than what we’re hearing about. Drug and exercise, exercise has failed us. Diet has failed us. So drug is the way to make it so that people who can’t lose weight have to take it. But it’s not a shock. You go sell it, I don’t care.”